Fri, 02/26/2010 - 14:09

Shanghai RAAS to benefit from price cap hike

Shanghai. February 26. INTERFAX-CHINA - Shenzhen Stock Exchange-listed Shanghai RAAS Blood Products Co. Ltd. announced on Feb. 26 that it will benefit from a blood product price cap rise in Shanghai.

This article is only accessible to Interfax subscribers. To gain access to this article, as well similar in-depth articles and industry-specific content, please contact our sales staff by telephone (+852 2537 2262) .

Start free trial NOW

News

All News
Telecom Media & Technology
Metals & Mining
Energy
Pharmaceuticals

Login

Interviews

07/30 17:25
Chinese games poised to compete abroad – Shi Hai, CEO of Snail Game

07/14 16:45
Opportunities abound in China's steel industry - Jing Ou-Yang of General Steel Holdings

06/30 16:55
China Clean Energy expects growth from biodiesel business - William Chen, CFO of China Clean Energy Inc.